Cargando…
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/ https://www.ncbi.nlm.nih.gov/pubmed/33374759 http://dx.doi.org/10.3390/molecules26010039 |
_version_ | 1783634533678055424 |
---|---|
author | Khan, Mujeeb Adil, Syed F. Alkhathlan, Hamad Z. Tahir, Muhammad N. Saif, Sadia Khan, Merajuddin Khan, Shams T. |
author_facet | Khan, Mujeeb Adil, Syed F. Alkhathlan, Hamad Z. Tahir, Muhammad N. Saif, Sadia Khan, Merajuddin Khan, Shams T. |
author_sort | Khan, Mujeeb |
collection | PubMed |
description | Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly contagious in nature and/or have caused high mortalities. The recently emerged COVID-19 disease is a highly transmittable viral infection caused by another zoonotic novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have been serving as established reservoirs for various pathogenic coronaviruses. Although, it is still unknown how SARS-CoV-2 is transmitted from bats to humans, the rapid human-to-human transmission has been confirmed widely. The disease first appeared in Wuhan, China, in December 2019 and quickly spread across the globe, infected 48,539,872 people, and caused 1,232,791 deaths in 215 countries, and the infection is still spreading at the time of manuscript preparation. So far, there is no definite line of treatment which has been approved or vaccine which is available. However, different types of potential vaccines and therapeutics have been evaluated and/or are under clinical trials against COVID-19. In this review, we summarize different types of acute respiratory diseases and briefly discuss earlier outbreaks of coronaviruses and compare their occurrence and pathogenicity with the current COVID-19 pandemic. Various epidemiological aspects of COVID-19 such as mode of spread, death rate, doubling time, etc., have been discussed in detail. Apart from this, different technical issues related to the COVID-19 pandemic including use of masks and other socio-economic problems associated with the pandemic have also been summarized. Additionally, we have reviewed various aspects of patient management strategies including mechanism of action, available diagnostic tools, etc., and also discussed different strategies for the development of effective vaccines and therapeutic combinations to deal with this viral outbreak. Overall, by the inclusion of various references, this review covers, in detail, the most important aspects of the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-7795815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77958152021-01-10 COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Khan, Mujeeb Adil, Syed F. Alkhathlan, Hamad Z. Tahir, Muhammad N. Saif, Sadia Khan, Merajuddin Khan, Shams T. Molecules Review Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly contagious in nature and/or have caused high mortalities. The recently emerged COVID-19 disease is a highly transmittable viral infection caused by another zoonotic novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have been serving as established reservoirs for various pathogenic coronaviruses. Although, it is still unknown how SARS-CoV-2 is transmitted from bats to humans, the rapid human-to-human transmission has been confirmed widely. The disease first appeared in Wuhan, China, in December 2019 and quickly spread across the globe, infected 48,539,872 people, and caused 1,232,791 deaths in 215 countries, and the infection is still spreading at the time of manuscript preparation. So far, there is no definite line of treatment which has been approved or vaccine which is available. However, different types of potential vaccines and therapeutics have been evaluated and/or are under clinical trials against COVID-19. In this review, we summarize different types of acute respiratory diseases and briefly discuss earlier outbreaks of coronaviruses and compare their occurrence and pathogenicity with the current COVID-19 pandemic. Various epidemiological aspects of COVID-19 such as mode of spread, death rate, doubling time, etc., have been discussed in detail. Apart from this, different technical issues related to the COVID-19 pandemic including use of masks and other socio-economic problems associated with the pandemic have also been summarized. Additionally, we have reviewed various aspects of patient management strategies including mechanism of action, available diagnostic tools, etc., and also discussed different strategies for the development of effective vaccines and therapeutic combinations to deal with this viral outbreak. Overall, by the inclusion of various references, this review covers, in detail, the most important aspects of the COVID-19 pandemic. MDPI 2020-12-23 /pmc/articles/PMC7795815/ /pubmed/33374759 http://dx.doi.org/10.3390/molecules26010039 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khan, Mujeeb Adil, Syed F. Alkhathlan, Hamad Z. Tahir, Muhammad N. Saif, Sadia Khan, Merajuddin Khan, Shams T. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title | COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title_full | COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title_fullStr | COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title_full_unstemmed | COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title_short | COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far |
title_sort | covid-19: a global challenge with old history, epidemiology and progress so far |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/ https://www.ncbi.nlm.nih.gov/pubmed/33374759 http://dx.doi.org/10.3390/molecules26010039 |
work_keys_str_mv | AT khanmujeeb covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT adilsyedf covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT alkhathlanhamadz covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT tahirmuhammadn covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT saifsadia covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT khanmerajuddin covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar AT khanshamst covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar |